scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0360-3016(00)00782-3 |
P698 | PubMed publication ID | 11121627 |
P50 | author | Lorraine A. Champion | Q98636626 |
P2093 | author name string | G Wong | |
R Stevens | |||
C Scott | |||
J Fisher | |||
M V Pilepich | |||
J D Gagnon | |||
B Marconi | |||
F Asrari | |||
G M Freedman | |||
P2860 | cites work | Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity | Q71727501 |
Biafine applied on human epidermal wounds is chemotactic for macrophages and increases the IL-1/IL-6 ratio | Q74115394 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1307-1310 | |
P577 | publication date | 2000-12-01 | |
P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
P1476 | title | Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13 | |
P478 | volume | 48 |
Q57138751 | Q57138751 |
Q51754299 | A Prospective Randomized, Placebo-Controlled Skin Care Study in Women Diagnosed With Breast Cancer Undergoing Radiation Therapy |
Q26771210 | A Review of the Use of Topical Calendula in the Prevention and Treatment of Radiotherapy-Induced Skin Reactions |
Q36164303 | A double-blind randomised controlled trial of a natural oil-based emulsion (Moogoo Udder Cream®) containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer. |
Q36453808 | A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients |
Q33723980 | Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years |
Q33662782 | Acute radiation dermatitis in breast cancer patients: challenges and solutions |
Q34361075 | Aloe vera for prevention of radiation-induced dermatitis: a self-controlled clinical trial |
Q42368017 | An Aloe Vera-Based Cosmeceutical Cream Delays and Mitigates Ionizing Radiation-Induced Dermatitis in Head and Neck Cancer Patients Undergoing Curative Radiotherapy: A Clinical Study |
Q47322784 | Are there biologic differences between male and female breast cancer explaining inferior outcome of men despite equal stage and treatment?! |
Q33707219 | Assessment and Comparison of Homogeneity and Conformity Indexes in Step-and-Shoot and Compensator-Based Intensity Modulated Radiation Therapy (IMRT) and Three-Dimensional Conformal Radiation Therapy (3D CRT) in Prostate Cancer |
Q89496335 | Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population |
Q92705676 | Botulinum Neurotoxins and Cancer-A Review of the Literature |
Q37288561 | Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation |
Q56981151 | Calendula officinalis: Potential Roles in Cancer Treatment and Palliative Care |
Q34940071 | Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. |
Q33582645 | Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection. |
Q35439699 | Conservative procedures in skin reconstitution. |
Q57787391 | Correlation Between Dosimetric Parameters and Acute Dermatitis of Post-operative Radiotherapy in Breast Cancer Patients |
Q36550581 | Correlation between anthropometric parameters and acute skin toxicity in breast cancer radiotherapy patients: a pilot assessment study |
Q28972351 | Current role of modern radiotherapy techniques in the management of breast cancer |
Q36228543 | Dose coverage of axillary level I-III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patients |
Q92684114 | Dosimetric comparison between three- and four-dimensional computerised tomography radiotherapy for breast cancer |
Q48353206 | Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer |
Q36634391 | Effect of Bra Use during Radiotherapy for Large-Breasted Women: Acute Toxicity and Treated Heart and Lung Volumes |
Q64235946 | Effectiveness, safety, and economic evaluation of topical application of a herbal ointment, Jaungo, for radiation dermatitis after breast conserving surgery in patients with breast cancer (GREEN study): Study protocol for a randomized controlled tria |
Q36687110 | Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS). |
Q37954519 | Hypofractionated radiation therapy in the treatment of early-stage breast cancer |
Q34391739 | Hypofractionated radiotherapy in the treatment of early breast cancer |
Q37720595 | Intensity-modulated radiation therapy for early-stage breast cancer: is it ready for prime time? |
Q46701128 | Interest of a sterilised anti-burning gel in radiation dermatitis: results of a comparative study |
Q37549486 | Long-term results of forward intensity-modulated radiation therapy for patients with early-stage breast cancer |
Q34367737 | Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4 |
Q82436653 | Objective Assessment of Dermatitis Following Post-operative Radiotherapy in Patients with Breast Cancer Treated with Breast-conserving Treatment |
Q44828020 | Outcomes research in cancer clinical trial cooperative groups: the RTOG model |
Q79329677 | Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy |
Q37175665 | Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy |
Q43715573 | Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy |
Q35999596 | Photobiomodulation for the management of radiation dermatitis: the DERMIS trial, a pilot study of MLS(®) laser therapy in breast cancer patients |
Q30613382 | Post mastectomy linac IMRT irradiation of chest wall and regional nodes: dosimetry data and acute toxicities |
Q38110447 | Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia |
Q31149109 | Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials |
Q37353578 | Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts |
Q34035512 | Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature |
Q89631380 | Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial |
Q81312385 | Quality of life of women treated with radiotherapy for breast cancer |
Q46701133 | Radiation induced skin reactions |
Q60937732 | Radiation-induced skin reactions: mechanism and treatment |
Q45843318 | Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies. |
Q27310815 | Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models. |
Q57755658 | Role and mechanism of radiological protection cream in treating radiation dermatitis in rats |
Q35553856 | Symptom Control |
Q37345699 | Symptom management in premenopausal patients with breast cancer |
Q33817013 | The clinical features and pathophysiology of acute radiation dermatitis in patients receiving tomotherapy |
Q34482444 | The effect of laughter therapy on radiation dermatitis in patients with breast cancer: a single-blind prospective pilot study |
Q55365327 | The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women. |
Q28244712 | The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline |
Q34325462 | The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study |
Q38052024 | Topical agent therapy for prevention and treatment of radiodermatitis: a meta-analysis |
Q37604785 | Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial |
Q82067637 | Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer |
Q36046400 | Topical use of olive oil preparation to prevent radiodermatitis: results of a prospective study in nasopharyngeal carcinoma patients |
Q38852495 | Trolamine emulsion for the prevention of radiation dermatitis in patients with squamous cell carcinoma of the head and neck |
Q55350916 | Use of trolamine to prevent and treat acute radiation dermatitis: a systematic review and meta-analysis. |
Q34418407 | Validation of the cell cycle G(2) delay assay in assessing ionizing radiation sensitivity and breast cancer risk |
Q36133827 | Volumetric modulated arc therapy for synchronous bilateral whole breast irradiation - A case study |
Search more.